Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Development of a Factor VIII-Specific Immunotherapy for Hemophilia A

Anja Naumann, Jörg Kahle, Nadia Reiss, Dirk Schwabe, Christine Heller, Thomas Klingebiel, MD, Christoph Königs, MD, PhD

Blood (2012) 120 (21): 3361.

https://doi.org/10.1182/blood.V120.21.3361.3361

Published: 2012

Journal Articles

Epitope Mapping of FIX Inhibitors Identify Contact Residues in the Protease Domain.

Sebastian Hoehl, Wolfhart Kreuz, MD, Nicole Krause, Diana Stichel, Inmaculada Martinez-Saguer, Christoph Kessel, Thomas Klingebiel, MD, Johannes Oldenburg, MD, PhD, James Irving, Christoph Königs

Blood (2009) 114 (22): 3172.

https://doi.org/10.1182/blood.V114.22.3172.3172

Published: 2009

Journal Articles

Peptide Multimers for Binding of Factor VIII Inhibitors.

Christoph Kessel, Wolfhart Kreuz, Katharina Klich, Frank Vorpahl, Karin Becker-Peters, Ursula Dietrich, Thomas Klingebiel, Christoph Königs

Blood (2008) 112 (11): 1224.

https://doi.org/10.1182/blood.V112.11.1224.1224

Published: 2008

Journal Articles

Inhibitor Epitopes Identified from Inhibitor Positive Plasma of a Hemophilia B Patient Change during ITT.

Christoph Königs, Christoph Kessel, Susanne Stumpf, Janti Roland, Thomas Klingebiel, Wolfhart Kreuz

Blood (2005) 106 (11): 3201.

https://doi.org/10.1182/blood.V106.11.3201.3201

Published: 2005

Journal Articles

Epitope Mapping of Inhibitors in Acquired Hemophilia by Phage Display.

Christoph Königs, Christoph Kessel, Sabine Scholz, Susanne Stumpf, Manuela Krause, Thomas Klingebiel, Wolfhart Kreuz

Blood (2005) 106 (11): 3202.

https://doi.org/10.1182/blood.V106.11.3202.3202

Published: 2005

Journal Articles

Ligand Mediated Targeting of FVIII Inhibitor Specific Primary B Cells Via Surface Immunoglobulin.

Christoph Kessel, Wolfhart Kreuz, Katharina Brassat, Thomas Klingebiel, Christoph Königs

Blood (2005) 106 (11): 3206.

https://doi.org/10.1182/blood.V106.11.3206.3206

Published: 2005

Journal Articles

Subcutaneous Immunoglobulin Substitutions in Previously Untreated (PUPs) and Treated Patients (PTPs) Result in Rapid Improvement of Total and Serum IgG Levels - a Novel Substitution Protocol for PUPs.

Christoph Königs, Dominik Dunsch, Richard Linde, Thomas Klingebiel, Prof, Dr, Wolfhart Kreuz, PD

Blood (2004) 104 (11): 3832.

https://doi.org/10.1182/blood.V104.11.3832.3832

Published: 2004

Journal Articles

Epitope Mapping during FVIII Inhibitor Elimination with Rituximab Revealed Conformational Epitopes on FVIII and Identifies Potentially Small Molecules for Novel Therapies.

Christoph Königs, BSc(Hons), Christoph Kessel, Dipl Biol, Richard Linde, Thomas Klingebiel, Wolfhart Kreuz, PD

Blood (2004) 104 (11): 3081.

https://doi.org/10.1182/blood.V104.11.3081.3081

Published: 2004

NARROW

Development of a Factor VIII-Specific Immunotherapy for Hemophilia A

Epitope Mapping of FIX Inhibitors Identify Contact Residues in the Protease Domain.

Peptide Multimers for Binding of Factor VIII Inhibitors.

Inhibitor Epitopes Identified from Inhibitor Positive Plasma of a Hemophilia B Patient Change during ITT.

Epitope Mapping of Inhibitors in Acquired Hemophilia by Phage Display.

Ligand Mediated Targeting of FVIII Inhibitor Specific Primary B Cells Via Surface Immunoglobulin.

Subcutaneous Immunoglobulin Substitutions in Previously Untreated (PUPs) and Treated Patients (PTPs) Result in Rapid Improvement of Total and Serum IgG Levels - a Novel Substitution Protocol for PUPs.

Epitope Mapping during FVIII Inhibitor Elimination with Rituximab Revealed Conformational Epitopes on FVIII and Identifies Potentially Small Molecules for Novel Therapies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only